Diverse impacts of aging on insulin resistance in lean and obese women with polycystic ovary syndrome: evidence from 1345 women with the syndrome.

No abstract is available for this paper.

• Publication year

  2014

• Venue

  European Journal of Endocrinology

• Publication date

  2014-09-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1530/EJE-13-1007PMID 25053727
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Effects of endogenous androgens and abdominal fat distribution on the interrelationship between insulin and non-insulin-mediated glucose uptake in females.

  2013cited by this paper
• Emergence of ovulatory cycles with aging in women with polycystic ovary syndrome (PCOS) alters the trajectory of cardiovascular and metabolic risk factors.

  2013cited by this paper
• Diabetes and cardiovascular events in women with polycystic ovary syndrome: a 20‐year retrospective cohort study

  2013cited by this paper
• Trajectories of cardiometabolic risk factors before diagnosis of three subtypes of type 2 diabetes: a post-hoc analysis of the longitudinal Whitehall II cohort study.

  2013cited by this paper
• Women with polycystic ovary syndrome have intrinsic insulin resistance on euglycaemic-hyperinsulaemic clamp.

  2013cited by this paper
• Age Associated Differences in Prevalence of Individual Rotterdam Criteria and Metabolic Risk Factors During Reproductive Age in 446 Caucasian Women with Polycystic Ovary Syndrome

  2012cited by this paper
• Polycystic Ovary Syndrome Is a Risk Factor for Type 2 Diabetes

  2012cited by this paper
• Insulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implications.

  2012cited by this paper
• Obesity is the predominant predictor of impaired glucose tolerance and metabolic disturbance in polycystic ovary syndrome

  2012cited by this paper
• Evaluation of adverse outcome in young women with polycystic ovary syndrome versus matched, reference controls: a retrospective, observational study.

  2012cited by this paper
• Cross-sectional analysis of the effects of age on the hormonal, metabolic, and ultrasonographic features and the prevalence of the different phenotypes of polycystic ovary syndrome.

  2012cited by this paper
• Assessment of Insulin Resistance and Impaired Glucose Tolerance in Lean Women with Polycystic Ovary Syndrome

  2011cited by this paper
• Diabetes and impaired glucose tolerance in patients with polycystic ovary syndrome--a long term follow-up.

  2011cited by this paper
• Cardiovascular disease and risk factors in PCOS women of postmenopausal age: a 21-year controlled follow-up study.

  2011cited by this paper
• Impaired glucose tolerance, type 2 diabetes and metabolic syndrome in polycystic ovary syndrome: a systematic review and meta-analysis.

  2010cited by this paper
• Age, Obesity, and Sex Effects on Insulin Sensitivity and Skeletal Muscle Mitochondrial Function

  2009cited by this paper
• The phenotype of polycystic ovary syndrome ameliorates with aging.

  2009cited by this paper
• Polycystic ovary syndrome is associated with tissue-specific differences in insulin resistance.

  2009cited by this paper
• Insulin resistance in skeletal muscle and adipose tissue in polycystic ovary syndrome: are the molecular mechanisms distinct from type 2 diabetes?

  2008cited by this paper
• The age-associated decline of androgens in reproductive age and menopausal Black and White women.

  2007cited by this paper
• Defining constant versus variable phenotypic features of women with polycystic ovary syndrome using different ethnic groups and populations.

  2006cited by this paper
• Effect of breast feeding on intelligence in children: prospective study, sibling pairs analysis, and meta-analysis

  2006cited by this paper
• PCOS according to the Rotterdam consensus criteria: change in prevalence among WHO‐II anovulation and association with metabolic factors

  2006cited by this paper
• Sex differences of endogenous sex hormones and risk of type 2 diabetes: a systematic review and meta-analysis.

  2006cited by this paper
• Effects of race and family history of type 2 diabetes on metabolic status of women with polycystic ovary syndrome.

  2005cited by this paper
• Androgen levels in adult females: changes with age, menopause, and oophorectomy.

  2005cited by this paper
• Prevalence and characteristics of the metabolic syndrome in women with polycystic ovary syndrome.

  2005cited by this paper
• Changes in glucose tolerance over time in women with polycystic ovary syndrome: a controlled study.

  2005cited by this paper
• Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS).

  2004cited by this paper
• Men at risk: occupation and male infertility.

  2004cited by this paper
• A mathematical comparison of techniques to predict biologically available testosterone in a cohort of 1072 men.

  2004cited by this paper
• Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome.

  2004cited by this paper
• Mechanisms of the age-associated deterioration in glucose tolerance: contribution of alterations in insulin secretion, action, and clearance.

  2003cited by this paper
• Aging and insulin secretion.

  2003cited by this paper
• Screening for abnormal glucose tolerance in adolescents with polycystic ovary syndrome.

  2002cited by this paper
• Prevalence of diabetes mellitus, hypertension and cardiac complaints in a follow-up study of a Dutch PCOS population.

  2001cited by this paper
• Age-related differences in features associated with polycystic ovary syndrome in normogonadotrophic oligo-amenorrhoeic infertile women of reproductive years.

  2001cited by this paper
• Relative risk of conversion from normoglycaemia to impaired glucose tolerance or non-insulin dependent diabetes mellitus in polycystic ovarian syndrome.

  2001cited by this paper
• Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome.

  1999cited by this paper
• A survey of the polycystic ovary syndrome in the Greek island of Lesbos: hormonal and metabolic profile.

  1999cited by this paper
• The natural history of the metabolic syndrome in young women with the polycystic ovary syndrome and the effect of long‐term oestrogen–progestagen treatment

  1999cited by this paper
• Insulin regulation of human ovarian androgens.

  1997cited by this paper
• Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis.

  1997cited by this paper
• A Prospective Analysis of the HOMA Model: The Mexico City Diabetes Study

  1996cited by this paper
• The insulin resistance in women with hyperandrogenism is partially reversed by antiandrogen treatment: evidence that androgens impair insulin action in women.

  1996cited by this paper
• Insulin resistance and insulin secretory dysfunction as precursors of non-insulin-dependent diabetes mellitus. Prospective studies of Pima Indians.

  1993cited by this paper
• Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man

  1985cited by this paper

• The impact of age on clinical features and fertility outcomes in patients with polycystic ovary syndrome: a secondary analysis based on the PCOSAct trial

  2026cites this paper
• The impact of obesogenic disturbances on in vitro fertilization outcomes in a Mexican population.

  2025cites this paper
• Weight-neutral approach and later sleep midpoint in adolescents with “emerging polycystic ovary syndrome phenotype” as vehicles for sustainable weight loss

  2024cites this paper
• European survey of diagnosis and management of the polycystic ovary syndrome: full report on the ESE PCOS Special Interest Group's 2023 Questionnaire.

  2024cites this paper
• Productivity loss due to polycystic ovary syndrome and its relationship to race, mental health and healthcare delivery indices

  2024cites this paper
• Assessment of Type 2 Diabetes Risk in Young Women with Polycystic Ovary Syndrome

  2023cites this paper
• Can dysglycemia in OGTT be predicted by baseline parameters in patients with PCOS?

  2022cites this paper
• Higher risk of type 2 diabetes in young women with polycystic ovary syndrome: A 10-year retrospective cohort study

  2022cites this paper
• Polycystic ovary syndrome and type 2 diabetes mellitus: A state-of-the-art review

  2022cites this paper
• Can dysglycemia in OGTT be predicted by baseline parameters in patients with PCOS?

  2022cites this paper
• Randomized clinical trial: effect of low-dose flutamide on abdominal adipogenic function in normal-weight women with polycystic ovary syndrome.

  2022cites this paper
• The complex metabolic interactions of liver tissue and hepatic exosome in PCOS mice at young and middle age

  2022cites this paper
• Updates on Molecular Targets and Epigenetic-Based Therapies for PCOS

  2022cites this paper
• Resistance to the Insulin and Elevated Level of Androgen: A Major Cause of Polycystic Ovary Syndrome

  2021influential citation
• Dehydroepiandrosterone Sulfate (DHEAS) Levels in Polycystic Ovarian Syndrome (PCOS).

  2021cites this paper
• Prevalence and Predictors of Impaired Glucose Tolerance and Diabetes Mellitus Type 2 in Patients with Polycystic Ovary Syndrome

  2021cites this paper
• Effect of aging on clinical features and metabolic complications of women with polycystic ovary syndrome

  2021cites this paper
• The Relationship Between Polycystic Ovarian Syndrome, Periodontal Disease, and Osteoporosis

  2020cites this paper
• Unfavorable Hormonal and Psychologic Profile in Adult Women with a History of Premature Adrenarche and Pubarche, Compared to Women with Polycystic Ovary Syndrome

  2020cites this paper
• Clinical Impact of Insulin Resistance in Women with Polycystic Ovary Syndrome

  2020cites this paper
• Insulin resistance, androgens, and lipids are gradually improved in an age-dependent manner in lean women with polycystic ovary syndrome: insights from a large Caucasian cohort

  2020cites this paper
• Osteosarcopenia in reproductive-aged women with polycystic ovary syndrome: a multicenter case-control study.

  2020cites this paper
• Comparison of PCOS phenotypes in adolescent and young adult Mediterranean women with possible PCOS

  2020cites this paper
• Circulating neuregulin-1 levels in polycystic ovary syndrome

  2019cites this paper
• Changes in clinical and biochemical characteristics of polycystic ovary syndrome with advancing age

  2019cites this paper
• TMT Based Proteomic Analysis of Human Follicular Fluid From Overweight/Obese and Normal-Weight Patients With Polycystic Ovary Syndrome

  2019cites this paper
• Polycystic Ovary Syndrome-Related Risks in Postmenopausal Women

  2019cites this paper
• Clinical course of depression symptoms and predictors of enduring depression risk in women with polycystic ovary syndrome: Results of a longitudinal study.

  2019cites this paper
• Cardiometabolic risk in polycystic ovary syndrome

  2018cites this paper
• Links Between Polycystic Ovary Syndrome and Gestational Diabetes Mellitus

  2018cites this paper
• Cardiovascular risk in postmenopausal women with polycystic ovary syndrome.

  2018cites this paper
• Prenatal undernutrition affects the phenotypes of PCOS model rats.

  2018cites this paper
• Letter to the Editor: "Development and Risk Factors of Type 2 Diabetes in a Nationwide Population of Women With Polycystic Ovary Syndrome".

  2018cites this paper
• Overweight and obese but not normal weight women with PCOS are at increased risk of Type 2 diabetes mellitus—a prospective, population-based cohort study

  2017cites this paper
• Overweight and obese but not normal weight women with PCOS are at increased risk of Type 2 diabetes mellitus-a prospective population-based cohort study.

  2017cites this paper
• Is cardiovascular risk in women with PCOS a real risk? Current insights.

  2017cites this paper
• A STUDY OF ASSOCIATION OF SEX HORMONES WITH INSULIN RESISTANCE AND OBESITY FOR DIABETES MELLITUS RISK IN ADULT WOMEN

  2017cites this paper
• Women with polycystic ovary syndrome demonstrate worsening markers of cardiovascular risk over the short‐term despite declining hyperandrogenaemia: Results of a longitudinal study with community controls

  2017cites this paper
• Assessing Energy Requirements in Women With Polycystic Ovary Syndrome: A Comparison Against Doubly Labeled Water

  2017cites this paper
• Debates Regarding Lean Patients with Polycystic Ovary Syndrome: A Narrative Review

  2017cites this paper
• Insulin and the polycystic ovary syndrome.

  2017cites this paper
• Matrix metalloproteinases 2 and 9 and MMP9/NGAL complex activity in women with PCOS.

  2016cites this paper
• Insulin Resistance and Polycystic Ovary Syndrome.

  2016cites this paper
• Targets to treat metabolic syndrome in polycystic ovary syndrome

  2015cites this paper
• Polycystic ovary syndrome: clinical implication in perimenopause

  2014cites this paper
• The Role of Metformin in Metabolic Disturbances during Pregnancy: Polycystic Ovary Syndrome and Gestational Diabetes Mellitus

  2014cites this paper